AIM ImmunoTech (AIM) Operating Leases (2019 - 2026)
AIM ImmunoTech's (AIM) quarterly Operating Leases came in at $360000.0 in Q1 2026, up 6.51% YoY from $338000.0 in Q1 2025, and up 111.76% on a QoQ basis from $170000.0 in Q4 2025.
AIM ImmunoTech (AIM) Operating Leases (2019 - 2026) Analysis & Trends
AIM ImmunoTech (AIM) has 8 years of Operating Leases data on file, last reported at $360000.0 in Q1 2026.
- Quarterly Operating Leases rose 6.51% year-over-year to $360000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $360000.0 (up 6.51% YoY) and the FY2025 annual result came in at $170000.0, down 73.19% from the prior year.
- Operating Leases advanced to $360000.0 in Q1 2026, from $170000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $889000.0 in Q2 2022 to a low of $84000.0 in Q1 2022.
- A 5-year average of $509000.0 and a median of $515000.0 in 2025 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases surged 870.24% — and 2025, when it tumbled 73.19%.
- Tracing AIM's Operating Leases over 5 years: stood at $659000.0 in 2022, then fell by 24.89% to $495000.0 in 2023, then advanced by 28.08% to $634000.0 in 2024, then plunged by 73.19% to $170000.0 in 2025, then soared by 111.76% to $360000.0 in 2026.
- The last three Operating Leases figures came in at $360000.0 (Q1 2026), $170000.0 (Q4 2025), and $226000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | AIM ImmunoTech | 4.34 Mn | -5.62 Mn | 21,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 300,000.00 |
| Mar 31, 2026 | 360,000.00 |
| Dec 31, 2025 | 170,000.00 |
| Sep 30, 2025 | 226,000.00 |
| Jun 30, 2025 | 515,000.00 |
| Mar 31, 2025 | 338,000.00 |
| Dec 31, 2024 | 634,000.00 |
| Sep 30, 2024 | 437,000.00 |
| Jun 30, 2024 | 488,000.00 |
| Mar 31, 2024 | 537,000.00 |
| Dec 31, 2023 | 495,000.00 |
| Sep 30, 2023 | 543,000.00 |
| Jun 30, 2023 | 597,000.00 |
| Mar 31, 2023 | 815,000.00 |
| Dec 31, 2022 | 659,000.00 |
| Sep 30, 2022 | 866,000.00 |
| Jun 30, 2022 | 889,000.00 |
| Mar 31, 2022 | 84,000.00 |
| Dec 31, 2021 | 112,000.00 |
| Sep 30, 2021 | 108,000.00 |